English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine Healthcare & Pharm
Kangji Medical Receives Privatisation Proposal from a Consortium Led by Kangji Medical's Chairman, Zhong Ming, TPG and QIA to Advance Long-Term Strategic Vision
Aug 13, 2025 11:27 HKT
康基医疗收到由董事长钟鸣、TPG及卡塔尔投资局(QIA)牵头财团提出的私有化要约 助力公司实现长远愿景
Aug 13, 2025 09:27 HKT
康基醫療收到由董事長鍾鳴、TPG及卡塔爾投資局(QIA)牽頭財團提出之私有化要約 助力公司實現長遠願景
Aug 13, 2025 09:27 HKT
Formerra 成為 Syensqo PVDF 的北美區經銷商
Aug 13, 2025 07:00 HKT
Formerra Becomes North American Distributor for Syensqo PVDF
Aug 12, 2025 21:00 HKT
Cryofocus Medtech Achieves Record Interim Results with 162% Revenue Surge Driven by Respiratory Intervention Products
Aug 11, 2025 10:41 HKT
康灃生物中期業績創紀錄 呼吸介入產品驅動收入激增162%
Aug 11, 2025 10:41 HKT
云顶新耀耐赋康(R)扩产获批 亚洲全域完全批准双突破 加速迈向50亿销售峰值
Aug 08, 2025 18:09 HKT
雲頂新耀耐賦康(R)擴產獲批 亞洲全域完全批准雙突破 加速邁向50億銷售峰值
Aug 08, 2025 18:09 HKT
Everest Medicines Announces Full Approval of NEFECON(R) in Taiwan
Aug 08, 2025 18:09 HKT
TruMerit 推出全球首個針對初級普通護理人員的國際認證
Aug 06, 2025 21:00 HKT
Cornerstone Robotics Completes World's First Clinical Validation of Autonomous Surgery Performed by Robot-Assisted Surgery
Aug 06, 2025 19:21 HKT
全球首例!康諾思騰手術機械人完成臨床場景下自主手術驗證
Aug 06, 2025 18:56 HKT
全球首例!康诺思腾手术机器人完成临床场景下自主手术验证
Aug 06, 2025 18:21 HKT
TruMerit Launches Global Credential for First-Level, General Nurses
Aug 06, 2025 09:00 HKT
全球首个IgA肾病对因治疗药物耐赋康®扩产获批 云顶新耀加速提升可及性与产能布局
Aug 05, 2025 10:21 HKT
NEFECON(R) Receives NMPA Approval for Production Expansion in China, as Everest Medicines Accelerates Accessibility and Capacity Efforts
Aug 05, 2025 10:21 HKT
全球首個IgA腎病對因治療藥物耐賦康®擴產獲批 雲頂新耀加速提升可及性與產能佈局
Aug 05, 2025 10:21 HKT
旅行者醫療支援平台 Traveler Care 正式全球上線,協助旅遊保險公司減少 80% 急診索賠
Aug 04, 2025 23:00 HKT
Traveler Care Launches Global Medical Dispatch Platform to Help Travel Insurance Companies Cut ER Claims by 80%
Aug 04, 2025 21:00 HKT
<< Previous  Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: